MeDALL (Mechanisms of the Development of ALLergy) aims to generate novel knowledge on the mechanisms of initiation of allergy from early childhood to young adulthoood, in order to propose early diagnosis, prevention and targets for therapy.

A novel definition of phenotypes of allergic diseases and an integrative translational approach are needed to understand how a network of molecular and environmental factors can lead to complex allergic phenotypes.

To achieve its objectives, MeDALL is organised into 12 integrated Workpackages (WP), specifically designed both to foster transnational collaboration between experts from different aspects of the development of allergy-associated.

MeDALL is a collaborative project supported by the European Union under the Health Cooperation Work Programme of the 7th Framework programme (grant agreement number 261357).

The consortium encompasses 23 public and private institutions, including 3 European SMEs, who will combine their efforts to contribute to the elucidation of the mechanisms of allergy-associated diseases. The consortium is gathering leading experts in clinical allergy (allergology, asthma, atopic dermatitis, food allergy, pediatrics), epidemiology, genetics, immunology, molecular biology, allergen biochemistry and bioinformatics.